Physician profile
Anne Georgulas
NPI 1538248091
$330.66
in general payments reported to CMS, 2019-2025
12 companies · $14.76 in 2025
The $14.76 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.38 · 2020: $58.08 · 2021: $139 · 2022: $36.99 · 2024: $24.07 · 2025: $14.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $63.48 | 2019-2021 | |
| Cranial Technologies, INC | $62.93 | 2019-2021 | |
| Corium, LLC | $36.49 | 2021-2022 | |
| Pfizer INC. | $28.02 | 2021 | |
| Merck Sharp & Dohme LLC | $25.80 | 2020-2021 | |
| Glaxosmithkline, LLC. | $24.07 | 2024 | Shingrix, Arexvy, Bexsero |
| Seqirus USA INC | $20.16 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.57 | 2020 | |
| Novo Nordisk INC | $14.76 | 2025 | Wegovy |
| Supernus Pharmaceuticals, INC. | $14.19 | 2022 | |
| Sanofi Pasteur INC. | $12.75 | 2019 | |
| Adlon Therapeutics L.P. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Georgulas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.